iRhythm Technologies IncChange company Symbol lookupSelect an option...IRTC iRhythm Technologies Inc$ICEFSTS ICE FactSet Taiwan Core SemiconductoUGRO Urban-Gro IncNVVEW Nuvve Holding Equity Warrants Exp 19 March 2026 *W EXP 03/19/2026AGNCN AGNC Investment CorpXJMMX Nuveen Multi-Market Income Fund IncTHDDY TV Asahi Holdings CorpABCB Ameris BancorpNSAUF MegumaGold CorpTSIBW Tishman Speyer Innovation Equity II Warrant Exp 11 Feb 2026 *W EXP 02/11/2026Go
iRhythm Technologies, Inc. is a digital healthcare company. It focuses on diagnosing cardiac arrhythmias by combining its wearable biosensing technology with cloud-based data analytics. It provides ambulatory electrocardiogram (ECG) monitoring for patients at risk for arrhythmias. It has created a portfolio of ambulatory cardiac monitoring services on a platform, called the Zio service. Its Zio service consists of wearable patch-based biosensors, Zio XT and Zio AT monitors, which records and stores ECG data from every patient heartbeat for up to 14 consecutive days. Zio service then provides cloud-based analysis of the recorded cardiac rhythms using its algorithms, an assessment review of the data by its cardiographic technicians, a report called Zio report, which includes the summary of findings and finally its cloud-based digital information system, ZioSuite, allows clinicians to connect via a Web browser or mobile application for online report interpretation and clinical workflows.
|
|
|
|
| |
Company Profile
iRhythm Technologies, Inc. is a digital healthcare company. It focuses on diagnosing cardiac arrhythmias by combining its wearable biosensing technology with cloud-based data analytics. It provides ambulatory electrocardiogram (ECG) monitoring for patients at risk for arrhythmias. It has created a portfolio of ambulatory cardiac monitoring services on a platform, called the Zio service. Its Zio service consists of wearable patch-based biosensors, Zio XT and Zio AT monitors, which records and stores ECG data from every patient heartbeat for up to 14 consecutive days. Zio service then provides cloud-based analysis of the recorded cardiac rhythms using its algorithms, an assessment review of the data by its cardiographic technicians, a report called Zio report, which includes the summary of findings and finally its cloud-based digital information system, ZioSuite, allows clinicians to connect via a Web browser or mobile application for online report interpretation and clinical workflows.
Valuation Ratios
- Price/Earnings (TTM)
- --
- Price/Sales (TTM)
- 11.84x
- Price/Book (MRQ)
- 12.80x
- Price/Cash Flow (TTM)
- --
MRQ = Most Recent Quarter
Price Performance
Financial Statements
Balance sheet
Values displayed are in millions.
Income statement
Values displayed are in thousands.
Cash flow
Values displayed are in thousands.
Company Officers
- Abhijit Y. Talwalkar
- Quentin S. BlackfordPres.
- Douglas J. DevineCEO
- Daniel G. WilsonExec.VP
- Mark J. DayExec.VP
Address
- 699 8Th Street, Suite 600
- San Francisco, CA 94103
- Phone: (415) 632-5700
- Fax: (302) 655-5049
- https://www.irhythmtech.com/
Insider Trading
No insider trading activity.
Insider trading information report provided by Copyright © 2022. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.